Dr Reddy’s Laboratories failed to cheer the market despite June quarter net profit doubling. Analysts see concern over the US business and pressure on operating performance as key drags. These concerns have prompted traders to build bearish bets on the stock. Chandan Taparia, derivative analyst at Motilal Oswal, said the weakness could continue and the stock could drift down to Rs 3,950.
Chandigarh man unearths 37-year-old Reliance shares worth Rs 12 lakh, ignites social media frenzy
Rattan Dillon, a car enthusiast from Chandigarh, stumbled upon physical share certificates of Reliance Industries (RIL) during a spring cleaning session. The certificates revealed that
March 12, 2025